Senores Pharmaceuticals share price
You have to be logged in to add this to Watchlist.- ₹829.50(0.96%)February 19, 2026 12:26:07 PM IST
- NSE
- BSE
- Vol : 102.64 K (NSE + BSE)Last 20 day avg : 217.47 K
Senores Pharmaceuticals is trading 0.96% upper at Rs 829.50 as compared to its last closing price. Senores Pharmaceuticals has been trading in the price range of 846.95 & 827.00. Senores Pharmaceuticals has given -0.01% in this year & 0.54% in the last 5 days. Senores Pharmaceuticals has TTM P/E ratio 36.69 as compared to the sector P/E of 23.86.There are 4 analysts who have initiated coverage on Senores Pharmaceuticals. There are 2 analysts who have given it a strong buy rating & 2 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 31.66 Crores in its last quarter.Listed peers of Senores Pharmaceuticals include Divi's Laboratories (0.59%), Cipla (-0.63%), Dr Reddy's Laboratories (0.41%).The Mutual Fund holding in Senores Pharmaceuticals was at 4.88% in 31 Dec 2025. The MF holding has increased from the last quarter. The FII holding in Senores Pharmaceuticals was at 3.35% in 31 Dec 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Feb 19, 2026, 07:05 AM UTC
- Debt To EquityHigher than industry0.40The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation0.13The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Divi's Laboratories | Neutral | 6,321.50 | 0.59 | 1,68,200.04 | 78.61 | 11.52 | 0.46 | 0.01 |
| Cipla | Neutral | 1,340.55 | -0.63 | 1,08,375.40 | 22.95 | 3.87 | 0.87 | 0.81 |
| Dr Reddy's Laboratories | Bullish | 1,286.05 | 0.41 | 1,07,152.75 | 18.63 | 3.14 | 0.63 | 2.34 |
| Sun Pharmaceutical Industries | Bullish | 1,720.70 | -0.21 | 4,12,700.23 | 36.24 | 5.77 | 0.92 | 0.50 |
| Torrent Pharmaceuticals | Bullish | 4,242.60 | 0.78 | 1,43,661.59 | 67.32 | 17.1 | 0.83 | 17.62 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-01-20 | Quarterly Results & Others |
| 2026-01-07 | Others |
| 2025-11-06 | Quarterly Results |
| 2025-07-23 | Quarterly Results & Others |
| 2025-05-15 | Audited Results |
- IndustryBiotechnology & Drugs
- ISININE0RB801010
- BSE Code544319
- NSE CodeSENORES
Senores Pharmaceuticals is trading at 829.50 as on Thu Feb 19 2026 06:56:07. This is 0.96% upper as compared to its previous closing price of 821.60.
The market capitalization of Senores Pharmaceuticals is 3830.40 Cr as on Thu Feb 19 2026 06:56:07.
The average broker rating on Senores Pharmaceuticals is Strong Buy. The breakup of analyst rating is given below -
- 2 analysts have given a strong buy rating
- 2 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Senores Pharmaceuticals is 876.00 whereas the 52 wk low is 457.95
Senores Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 36.69
- Sector P/E: 23.86
- Dividend Yield: 0.00%
- D/E ratio: -
Senores Pharmaceuticals reported a net profit of 58.56 Cr in 2025.
The Mutual Fund Shareholding was 4.88% at the end of 31 Dec 2025.